Showing results (361-370 of 2,036) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|February 1, 1987
On the theory of the measurement of the first-pass pulmonary extraction using the indicator dilution techniqueS F AkberNuklearmedizin. Nuclear Medicine|April 6, 2021
[Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey]Lutz S Freudenberg, Markus Essler, Ken HerrmannNuklearmedizin. Nuclear Medicine|August 22, 2020
Improving quality of life in patients with metastatic prostate cancer following one cycle of 177Lu-PSMA-617 radioligand therapy: a pilot studyMilka Marinova, Reza Alamdar, Hojjat Ahmadzadehfar, et al.Nuklearmedizin. Nuclear Medicine|August 1, 1988
[133Xe-DSPECT: significance of the cerebrovascular reserve capacity for the diagnosis and therapy of chronic cerebral ischemia]G Leinsinger, P Schmiedek, T Kreisig, et al.Nuklearmedizin. Nuclear Medicine|December 1, 1991
[Bone marrow changes in patients with thyroid carcinoma]A Linden, R Weiss, K Smolarz, et al.Nuklearmedizin. Nuclear Medicine|March 20, 2009
Myocardial perfusion after one year of spinal cord stimulation in patients with refractory anginaEva Fricke, Siegfried Eckert, Aristidis Dongas, et al.Nuklearmedizin. Nuclear Medicine|August 11, 2007
[3D volume and SUV analysis of oncological PET studies: a voxel-based image processing tool with NSCLC as example]T Krohn, H-J Kaiser, B Gagel, et al.Nuklearmedizin. Nuclear Medicine|August 12, 2008
The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parametersR Buchert, F ThieleNuklearmedizin. Nuclear Medicine|June 1, 1991
The utility of fractional wash-out slope values following intravenous 133XeH Durak, C F Bekdik, N UlutuncelNuklearmedizin. Nuclear Medicine|June 1, 1991
[Hepatic hydrothorax without ascites]H Schöder, M FriedrichPageof 204